Orthopediatrics director gets 11,436-share stock grant

Riccitelli Samuel D reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Riccitelli Samuel D reported acquisition or exercise transactions in this Form 4 filing.

ORTHOPEDIATRICS CORP director Samuel D. Riccitelli received a stock grant of 11,436 shares of Common Stock. The award was granted at no cash cost per share and is held directly. Following this grant, he directly owns 31,859 shares, including restricted stock awards totaling 17,959 shares.

Insights

Equity compensation analyst

Director received routine stock grant, increasing direct holdings modestly.

Director Samuel D. Riccitelli acquired 11,436 shares of ORTHOPEDIATRICS CORP Common Stock through a grant labeled as a “Grant, award, or other acquisition.” The grant carried a price of $0.0000 per share, indicating compensation rather than a market purchase.

After this grant, his direct ownership rose to 31,859 shares, of which 17,959 are identified as restricted stock awards. This appears to be a standard equity compensation event for a director, not an open-market trade, so it carries limited signaling about his view of the stock’s short-term valuation.

Insider Trade Summary

Grant/Award: 11,436 shares

Grant/Award 1 txn

Insider Riccitelli Samuel D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	11,436	$0.00	$0.00

Holdings After Transaction: Common Stock — 31,859 shares (Direct)

Footnotes (1)

1. F1. Includes restricted stock awards totaling 17,959 shares.

Key Figures

Shares granted: 11,436 shares Grant price: $0.0000 per share Total shares after grant: 31,859 shares +1 more

4 metrics

Shares granted 11,436 shares Common Stock grant on 2026-06-09

Grant price $0.0000 per share Equity compensation, non-market transaction

Total shares after grant 31,859 shares Direct ownership following transaction

Restricted stock included 17,959 shares Restricted stock awards within total holdings

Key Terms

Common Stock, Grant, award, or other acquisition, restricted stock awards, Form 4

4 terms

Common Stock financial

"Samuel D. Riccitelli received a stock grant of 11,436 shares of Common Stock."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"The award was coded as a Grant, award, or other acquisition."

restricted stock awards financial

"Includes restricted stock awards totaling 17,959 shares."

Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.

Form 4 regulatory

"The KIDS Form 4 shows a stock award, not a market purchase."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did ORTHOPEDIATRICS CORP director Samuel D. Riccitelli report in this Form 4 for KIDS?

Director Samuel D. Riccitelli reported receiving 11,436 shares of ORTHOPEDIATRICS CORP Common Stock as a grant. The shares were awarded at no cash cost per share and increased his direct ownership to 31,859 shares, combining unrestricted and restricted stock awards.

Was the KIDS Form 4 transaction a market purchase or a stock award?

The KIDS Form 4 shows a stock award, not a market purchase. The transaction is coded as a grant or award, and the reported price is $0.0000 per share, indicating equity compensation granted by ORTHOPEDIATRICS CORP rather than shares bought on the open market.

How many ORTHOPEDIATRICS CORP shares does Samuel D. Riccitelli own after this Form 4 filing?

After the reported transaction, Samuel D. Riccitelli directly owns 31,859 shares of ORTHOPEDIATRICS CORP Common Stock. This total includes both unrestricted shares and restricted stock awards, with a footnote stating that 17,959 of these shares are restricted stock awards.

What does the footnote about restricted stock awards mean in the KIDS Form 4?

The footnote explains that Riccitelli’s reported holdings include restricted stock awards totaling 17,959 shares. Restricted stock awards typically vest over time or upon meeting conditions, so they are part of his beneficial ownership but may have limits on when they can be sold or transferred.

Does the KIDS Form 4 show any stock sales by Samuel D. Riccitelli?

The KIDS Form 4 does not show any stock sales by Samuel D. Riccitelli. It reports only an acquisition of 11,436 shares through a grant or award, with no dispositions, exercises, or open-market sales disclosed in this particular filing for ORTHOPEDIATRICS CORP.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/10/2026 - 09:49 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Riccitelli Samuel D

(Last) (First) (Middle)

C/O ORTHOPEDIATRICS CORP.

2850 FRONTIER DRIVE

(Street)

WARSAW INDIANA 46582

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ORTHOPEDIATRICS CORP [ KIDS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/09/2026		A		11,436	A	$0	31,859(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes restricted stock awards totaling 17,959 shares.

Remarks:

	/s/ Daniel J. Gerritzen, Attorney-in-Fact	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)